A Study to Compare the Pharmacokinetics (PK) of Depemokimab When Delivered With a Safety Syringe Device (SSD) or an Autoinjector in Healthy Adult Participants - NCT05602025

Maximum observed plasma concentration (Cmax) of depemokimab, Area under the concentration-time curve from time zero extrapolated to infinity (AUC[0-inf]) of depemokimab, Area under the concentration time curve from time zero to time of last observed quantifiable concentration (AUC[0-t]) of depemokimab, (and 8 more...)